Revised Global Consensus Statement on Menopausal Hormone Therapy

This Consensus Statement is endorsed by The International Menopause Society, The North American Menopause Society, The Endocrine Society, The European Menopause and Andropause Society, The Asia Pacific Menopause Federation, The International Osteoporosis Foundation and The Federation of Latin American Menopause Societies. 

The publication of the Global Consensus on Menopausal Hormone Therapy in 2013 by leading global menopause societies succeeded in presenting guidelines in a troubled therapeutic area that are helpful to both health-care providers and potential users of menopausal hormone therapy (MHT).

The revised statement is aimed at updating and expanding the areas of consensus. The revised statement is presented in bullet-point format to facilitate ease of use. The revised statement contains only areas of consensus and does not replace the more detailed and fully referenced recommendations of the individual societies (referenced at the end of the document). Hopefully, this statement will enable health-care providers to offer those women in midlife, who may benefit from MHT, the opportunity to make an informed decision. 

pdfRevised Global Consensus Statement on MHT285.89 KB 

Reference

T. J. de Villiers, J. E. Hall, J. V. Pinkerton, S. Cerdas PĂ©rez, M. Rees, C. Yang & D. D. Pierroz (2016): Revised Global Consensus Statement on Menopausal Hormone Therapy, Climacteric, DOI: 10.1080/13697137.2016.1196047

Content updated 6 September 2016

Print